5Garland SM, Hernandez-Avila M, Wheeler CM, et al. Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE I) in- vestigators. Quadrivalent vaccine against human papillomavirus to pre- vent anogenital diseases [ J ]. N Engl J Med, 2007, 356 ( 19 ) : 1928 - 1943. 被引量：1
6FUTURE II Study Group. Quadrivalent vaccine against human papil- lomavirus to prevent high grade cervical lesions [ J ]. N Engl J Med, 2007,356 (19) : 1915 - 1927. 被引量：1
7Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males[ J]. N Engl J Med ,2011,364(5 ) :401 -411. 被引量：1
8Etter DJ,Zimet GD, Rickert VI. Human papillomavirus vaccine in ad- olescent women : a 2012 update [ J ]. Curt Opin Obstet Gyneco1,2012, 24(5) :305 -310. 被引量：1
9Donovan B, Franklin N, Guy R, et al. Quadrivalent human papilloma- virus vaccination and trends in genital warts in Australia: analysisof national sentinel surveillance data [ J ]. Lancet Infect Dis, 2011,11 (1) :39 -44. 被引量：1
10Pan QJ, Hu SY, Zhang X, et al. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China [ J ]. Cancer Cytopathol, 2013, 121 (9) :473-482. 被引量：1
